Catch up on the top radiology content of the past week.
|Articles|May 9, 2001
Nuclear cardiology sites come aboard
Adding to its investment in positron imaging, Integral Nuclear Associates has purchased the assets of Nuclear Imaging Systems and Cardiovascular Concepts. These assets include 14 fixed-site nuclear cardiology imaging centers in Pennsylvania, New Jersey,
Advertisement
Adding to its investment in positron imaging, Integral Nuclear Associates has purchased the assets of Nuclear Imaging Systems and Cardiovascular Concepts. These assets include 14 fixed-site nuclear cardiology imaging centers in Pennsylvania, New Jersey, Delaware, and Maryland. The sellers had filed for bankruptcy under chapter 11 in August 2000. INA, which owns Integral PET, intends to incorporate its newly acquired sites into the nuclear cardiology business operated by the Integral group of companies. The centers provide a comprehensive range of nuclear cardiology services, including cardiac stress tests, SPECT, perfusion, and wall motion studies.
Advertisement
Related to this article
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears First MRI-Derived AI Software for Assessing Breast Cancer Recurrence Risk
2
What a Large Prostate MRI Study Reveals About AI and Unassisted Radiologist Assessment
3
Diagnostic Imaging's Weekly Scan: October 11 — October 17
4
How Photon-Counting CT Helps Us Recognize that Coronary Stenosis is Just One Piece of the Puzzle
5